Oxetane Grafts Installed Site‐Selectively on Native Disulfides to Enhance Protein Stability and Activity In Vivo

Nuria Martínez‐Sáez, Shuang Sun, Davide Oldrini, Pietro Sormanni, Omar Boutureira, Filippo Carboni, Ismael Compañón, Michael J. Deery, Michele Vendruscolo, Francisco Corzana, Roberto Adamo, Gonçalo J. L. BernardesAngewandte 2017 · DOI

TL;DR

Researchers have developed a novel, one-pot method to chemically "staple" proteins and peptides by introducing an oxetane ring across native disulfide bonds. This simple yet robust technique enhances protein stability and biological activity, showing promise for improving therapeutic proteins like antibodies and vaccine carriers.

What Problem Does This Paper Address?

Modifying the structure of peptides and proteins is a powerful way to tune their biological activity and stability. A common challenge is to achieve these modifications in a way that is efficient, site-specific, and compatible with complex biological molecules like full-length proteins. Previous methods for protein "stapling" often required complex orthogonal protection strategies, sequence engineering, or harsh reaction conditions, limiting their applicability to intact proteins. The authors sought a simpler, more generalizable method to introduce structural constraints into proteins and peptides by targeting native disulfide bonds, which are prevalent in many biologically active molecules.

Methods

The core of this work is a novel chemical reaction that utilizes a commercially available reagent, 3,3-bis(bromomethyl)oxetane (referred to as "oxetane 1"), to form a covalent oxetane bridge across a reduced disulfide bond. The process is described as a "one-pot" reaction, meaning all steps occur sequentially in the same reaction vessel.

Here's a breakdown of the key steps and features:

  • Disulfide Reduction: Native disulfide bonds in peptides and proteins are first reduced to free thiols. This is achieved using a mild reducing agent, tris(2-carboxyethyl)phosphine (TCEP), which is compatible with aqueous buffer systems.
  • Oxetane Grafting: The reduced thiols are then reacted with oxetane 1. The oxetane ring, with its strained four-membered structure, undergoes a bis-alkylation reaction with the two cysteine thiols, forming a stable, cyclic oxetane linkage.
  • Site-Selectivity: The reaction is designed to be site-selective, targeting specific disulfide bonds. In the case of proteins, this selectivity is often dictated by the accessibility of the disulfide bond to the reagent.
  • Mild and Biocompatible Conditions: The reactions are performed under mild conditions (room temperature to 37°C, aqueous buffered solutions, near-neutral pH), making them suitable for sensitive biomolecules.
  • Broad Substrate Scope: The authors demonstrate the applicability of this method to a range of molecules, including linear and cyclic peptides, proteins (like thioredoxin), and antibodies (Fab fragments and full antibodies).

Datasets

Not discussed in the paper. The study focuses on the chemical modification of existing peptides and proteins, rather than training models on large datasets.

Key Insights and Ideas

  • The Oxetane Ring as a "Staple": The oxetane ring is a surprisingly effective and versatile "staple" that can be readily incorporated into peptides and proteins. Its small size and chemical properties allow it to bridge disulfide bonds without causing major structural disruptions.
  • Simplicity and Robustness: The "one-pot" nature and mild reaction conditions are significant advantages, making this method highly practical for researchers working with complex biomolecules. It bypasses the need for complex purification steps between reduction and stapling.
  • Enhanced Stability and Activity: The oxetane staple not only stabilizes the folded structure of the biomolecule but also, in several cases, leads to improved biological activity. This suggests that the imposed conformational constraint can be beneficial for function.
  • Broad Applicability to Therapeutics: The successful demonstration of stapling on antibodies (Herceptin Fab, DesAb-Aβ) and a vaccine carrier protein (CRM197) highlights the potential of this method to improve existing and develop new therapeutic agents.
  • Immunogenicity Boost: For CRM197, oxetane stapling significantly increased its immunogenicity in mice, suggesting that improved stability can lead to a more potent immune response.

Key Results

  • Peptide Stapling: Cyclic peptides like somatostatin and octreotide were stapled with high yields (76% and 81%, respectively), resulting in derivatives with improved binding affinity to their target receptor (4-fold enhancement for somatostatin). Molecular dynamics simulations indicated that the stapled somatostatin adopted a more rigid and defined conformation.
  • Protein Stapling: Thioredoxin, a model protein, was successfully stapled, with the oxetane graft preserving its overall secondary structure while suppressing its redox activity.
  • Antibody Stapling:
    • A Fab fragment of Herceptin was stapled, yielding a product that was stable under reducing conditions and in human plasma. This stapled antibody showed a modest but significant increase in binding affinity to the Her2 receptor.
  • A designed antibody targeting Amyloid-β (DesAb-Aβ) was also stapled, even though its disulfide bond was deeply buried, demonstrating the method's robustness. The stapled antibody showed no significant change in secondary structure.
  • Vaccine Carrier Protein (CRM197): Oxetane stapling of CRM197 resulted in a statistically significant higher level of anti-protein antibodies in mice, with a threefold higher avidity for the protein antigen. This indicates enhanced immunogenicity.

Limitations and Future Work

  • Disulfide Accessibility: The authors acknowledge that the success of this method is dependent on the solvent accessibility of the disulfide bond within the protein of interest. Disulfides buried deep within the protein core might require more forcing conditions or may not be amenable to this specific stapling strategy.
  • Structural Impact: While the oxetane motif generally preserves secondary structure, molecular dynamics simulations suggested a slight increase in flexibility for some stapled proteins, which warrants further investigation.
  • Future Directions: The authors anticipate that this oxetane stapling strategy can be a general approach to enhance the in vivo stability and fine-tune the structure of therapeutic proteins containing disulfide bonds, leading to optimized pharmacokinetics and activity. Further exploration of its application across a wider range of therapeutic proteins is a natural next step.

Summary updated

Abstract

A four-membered oxygen ring (oxetane) can be readily grafted into native peptides and proteins through site-selective bis-alkylation of cysteine residues present as disulfides under mild and biocompatible conditions. The selective installation of the oxetane graft enhances stability and activity, as demonstrated for a range of biologically relevant cyclic peptides, including somatostatin, proteins, and antibodies, such as a Fab arm of the antibody Herceptin and a designed antibody DesAb-Aβ against the human Amyloid-β peptide. Oxetane grafting of the genetically detoxified diphtheria toxin CRM<sub>197</sub> improves significantly the immunogenicity of this protein in mice, which illustrates the general utility of this strategy to modulate the stability and biological activity of therapeutic proteins containing disulfides in their structures.
BibTeX
@inproceedings{martinezsaez2017oxetane,
  author = {Nuria Martínez‐Sáez and Shuang Sun and Davide Oldrini and Pietro Sormanni and Omar Boutureira and Filippo Carboni and Ismael Compañón and Michael J. Deery and Michele Vendruscolo and Francisco Corzana and Roberto Adamo and Gonçalo J. L. Bernardes},
  title = {{Oxetane Grafts Installed Site‐Selectively on Native Disulfides to Enhance Protein Stability and Activity In Vivo}},
  booktitle = {Angewandte},
  year = {2017},
  doi = {10.1002/anie.201708847},
}
Figure